Indivior Pharmaceuticals (INDV) Other Accumulated Expenses (2023 - 2025)
Indivior Pharmaceuticals (INDV) posted quarterly Other Accumulated Expenses of $3.0 million for Q1 2025, down 72.73% quarter-over-quarter from $11.0 million in Q4 2024.
Indivior Pharmaceuticals (INDV) Other Accumulated Expenses (2023 - 2025) Analysis & Trends
Indivior Pharmaceuticals' Other Accumulated Expenses history runs 3 years deep, the most recent figure standing at $3.0 million for Q1 2025.
- In Q1 2025, Other Accumulated Expenses changed N/A year-over-year to $3.0 million; the TTM figure through Mar 2025 stood at $3.0 million (changed N/A YoY), while the FY2024 annual figure was $11.0 million, down 72.5% from the prior year.
- Other Accumulated Expenses for Q1 2025 stood at $3.0 million, down from $11.0 million in the prior quarter.
- The five-year high for Other Accumulated Expenses was $40.0 million in Q4 2023, with the low at $3.0 million in Q1 2025.
- The 3-year median for Other Accumulated Expenses is $11.0 million (2024), against an average of $18.0 million.
- Peak annual rise in Other Accumulated Expenses reached 72.5% in 2024, while the deepest fall reached 72.5% in 2024.
- Indivior Pharmaceuticals' Other Accumulated Expenses stood at $40.0 million in 2023, then plunged by 72.5% to $11.0 million in 2024, then slumped by 72.73% to $3.0 million in 2025.
- Business Quant data shows INDV's Other Accumulated Expenses at $3.0 million in Q1 2025, $11.0 million in Q4 2024, and $40.0 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Indivior Pharmaceuticals | 4.53 Bn | 4.31 Bn | 294.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 11.00 Mn |
| Dec 31, 2023 | 40.00 Mn |